mortality/aging
• 70% die by 5 weeks of age, remainder grow normally to 3 months at least
|
cardiovascular system
• heart weight/body weight ratio 2X normal
(J:13736)
• increased cardiac cell volume
(J:13736)
• increased numbers of mitochondria in cardiac cells
(J:13736)
• increase in non-collagen protein in cardiac cells
(J:13736)
• greater growth in heart weight than normal
(J:40286)
• hypertrophy involves ventricles and not atria
(J:40286)
|
growth/size/body
• heart weight/body weight ratio 2X normal
(J:13736)
• increased cardiac cell volume
(J:13736)
• increased numbers of mitochondria in cardiac cells
(J:13736)
• increase in non-collagen protein in cardiac cells
(J:13736)
• greater growth in heart weight than normal
(J:40286)
• hypertrophy involves ventricles and not atria
(J:40286)
|
• growth was normal through 18 days but retarded by day 28
|
homeostasis/metabolism
• lower total serum carnitine levels while body levels as a whole were higher
|
aminoaciduria
(
J:18523
)
• increased levels of carnitine in the urine
|
• result of decreased activity of enzymes in the urea cycle
|
hypoglycemia
(
J:31000
)
liver/biliary system
• lipid containing microvesicles in hepatocytes
|
pale liver
(
J:14288
)
renal/urinary system
aminoaciduria
(
J:18523
)
• increased levels of carnitine in the urine
|
• lower kidney resorption of carnitine
|
reproductive system
N |
• males that survive beyond 5 weeks of age are fertile although weak
|
• flexed between the caput and the corpus
|
• proximal corpus swollen due to accumulation of spermatozoa, low columnar and cuboid epithelial cells
• in severe cases, the epithelium ruptures and spermatozoa are extravasated
• distal corpus constricted with no spermatozoa and an accumulation of eosinophilic debris, columnar epithelium
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
systemic primary carnitine deficiency disease | DOID:14365 |
OMIM:212140 |
J:13736 , J:14288 , J:18523 , J:31000 , J:31026 , J:40286 , J:51313 , J:53598 |